|
Siponimod Clinical Trials
2 actively recruiting trials across 2 locations
Also known as: Mayzent
Pipeline
Phase 2: 1
Top Sponsors
- St. Joseph's Hospital and Medical Center, Phoenix1
- Biogen1
Indications
- MCI With Increased Risk for Alzheimer Disease1
- Mild Alzheimer Disease1
- Alzheimer's Disease1
- Cognitive Impairment, Mild1
- Multiple Sclerosis1
Phoenix, Arizona1 trial
Repurposing Siponimod for Alzheimer's Disease
St. Joseph's Hospital and Medical Center
Phase 2
Eden Prairie, Minnesota1 trial
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.